EXERTIER, CECILE
EXERTIER, CECILE
Istituto di Biologia e Patologia Molecolari - IBPM
Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site
2023 Madia V.N.; Ialongo D.; Patacchini E.; Exertier C.; Antonelli L.; Colotti G.; Messore A.; Tudino V.; Saccoliti F.; Scipione L.; Ilari A.; Costi R.; Di Santo R.
Structural insights into the DNA recognition mechanism by the bacterial transcription factor PdxR
2023 Freda, I; Exertier, C; Barile, A; Chavessanjuan, A; Vega, Mv; Isupov, Mn; Harmer, Nj; Gugole, E; Swuec, P; Bolognesi, M; Scipioni, A; Savino, C; Di Salvo, Ml; Contestabile, R; Vallone, B; Tramonti, A; Montemiglio, Lc
Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design
2022 Fiorillo A.; Colotti G.; Exertier C.; Liuzzi A.; Seghetti F.; Salerno A.; Caciolla J.; Ilari A.
Neuroglobin, clues to function and mechanism
2022 Exertier, C; Montemiglio, Lc; Freda, I; Gugole, E; Parisi, G; Savino, C; Vallone, B
Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach
2022 Battista, T; Federico, S; Brogi, S; Pozzetti, L; Khan, T; Butini, S; Ramunno, A; Fiorentino, E; Orsini, S; Di Muccio, T; Fiorillo, A; Exertier, C; Di Risola, D; Colotti, G; Gemma, S; Ilari, A; Campiani, G
The nuts and bolts of SARS-CoV-2 spike receptor-binding domain heterologous expression
2021 Maffei, M; Montemiglio, Lc; Vitagliano, G; Fedele, L; Sellathurai, S; Bucci, F; Compagnone, M; Chiarini, V; Exertier, C; Muzi, A; Roscilli, G; Vallone, B; Marra, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site | 1-gen-2023 | Madia V.N.; Ialongo D.; Patacchini E.; Exertier C.; Antonelli L.; Colotti G.; Messore A.; Tudino V.; Saccoliti F.; Scipione L.; Ilari A.; Costi R.; Di Santo R. | |
| Structural insights into the DNA recognition mechanism by the bacterial transcription factor PdxR | 1-gen-2023 | Freda, I; Exertier, C; Barile, A; Chavessanjuan, A; Vega, Mv; Isupov, Mn; Harmer, Nj; Gugole, E; Swuec, P; Bolognesi, M; Scipioni, A; Savino, C; Di Salvo, Ml; Contestabile, R; Vallone, B; Tramonti, A; Montemiglio, Lc | |
| Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design | 1-gen-2022 | Fiorillo A.; Colotti G.; Exertier C.; Liuzzi A.; Seghetti F.; Salerno A.; Caciolla J.; Ilari A. | |
| Neuroglobin, clues to function and mechanism | 1-gen-2022 | Exertier, C; Montemiglio, Lc; Freda, I; Gugole, E; Parisi, G; Savino, C; Vallone, B | |
| Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach | 1-gen-2022 | Battista, T; Federico, S; Brogi, S; Pozzetti, L; Khan, T; Butini, S; Ramunno, A; Fiorentino, E; Orsini, S; Di Muccio, T; Fiorillo, A; Exertier, C; Di Risola, D; Colotti, G; Gemma, S; Ilari, A; Campiani, G | |
| The nuts and bolts of SARS-CoV-2 spike receptor-binding domain heterologous expression | 1-gen-2021 | Maffei, M; Montemiglio, Lc; Vitagliano, G; Fedele, L; Sellathurai, S; Bucci, F; Compagnone, M; Chiarini, V; Exertier, C; Muzi, A; Roscilli, G; Vallone, B; Marra, E |